Climb Bio, Inc. (CLYM)

10.94 -0.13 (-1.17%) USD  |  NASDAQ  |  Oct 02, 16:00
11.10 +0.16 (+1.46%) Pre-Market: 09:01
More

Climb Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CLYM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2025 --
Date Value
December 31, 2024 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Korsana Biosciences, Inc. Upgrade
Cullinan Therapeutics, Inc. Upgrade
Q32 Bio, Inc. Upgrade
Artiva Biotherapeutics, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade